Mathieu Bellal

414 total citations
5 papers, 46 citations indexed

About

Mathieu Bellal is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Mathieu Bellal has authored 5 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Mathieu Bellal's work include Lymphoma Diagnosis and Treatment (2 papers), Complement system in diseases (2 papers) and Advancements in Semiconductor Devices and Circuit Design (1 paper). Mathieu Bellal is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Complement system in diseases (2 papers) and Advancements in Semiconductor Devices and Circuit Design (1 paper). Mathieu Bellal collaborates with scholars based in France. Mathieu Bellal's co-authors include Gandhi Damaj, Damien du Cheyron, Julia Dina, Sylvain Chantepie, Valérie Châtelet, Hyacinthe Johnson‐Ansah, Jean‐Emmanuel Kahn, Agnès Veyradier, Anne‐Claire Gac and Y. Benhamou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Critical Care.

In The Last Decade

Mathieu Bellal

5 papers receiving 46 citations

Peers

Mathieu Bellal
Mathieu Bellal
Citations per year, relative to Mathieu Bellal Mathieu Bellal (= 1×) peers Nicolas Daguindau

Countries citing papers authored by Mathieu Bellal

Since Specialization
Citations

This map shows the geographic impact of Mathieu Bellal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bellal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bellal more than expected).

Fields of papers citing papers by Mathieu Bellal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Bellal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bellal. The network helps show where Mathieu Bellal may publish in the future.

Co-authorship network of co-authors of Mathieu Bellal

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Bellal. A scholar is included among the top collaborators of Mathieu Bellal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Bellal. Mathieu Bellal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Bellal, Mathieu, et al.. (2024). Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update. Critical Care. 28(1). 69–69. 18 indexed citations
2.
Morice, Pierre‐Marie, et al.. (2022). Management of diffuse large B‐cell lymphoma with cardiac and extra‐cardiac locations. SHILAP Revista de lepidopterología. 3(3). 1048–1049. 1 indexed citations
3.
Bellal, Mathieu, et al.. (2022). Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review. SHILAP Revista de lepidopterología. 2(4). 625–637. 5 indexed citations
4.
Picod, Adrien, Jean-Michel Rebibou, Antoine Dossier, et al.. (2022). Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination. Blood. 139(16). 2565–2569. 13 indexed citations
5.
Reman, Oumédaly, Julia Dina, Mathieu Bellal, et al.. (2019). Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. Current Research in Translational Medicine. 67(4). 145–148. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026